BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 36435955)

  • 1. Vitexin Improves Cerebral ischemia‑reperfusion Injury by Attenuating Oxidative Injury and Ferroptosis via Keap1/Nrf2/HO-1signaling.
    Guo L; Shi L
    Neurochem Res; 2023 Mar; 48(3):980-995. PubMed ID: 36435955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.
    Hu Q; Zuo T; Deng L; Chen S; Yu W; Liu S; Liu J; Wang X; Fan X; Dong Z
    Phytomedicine; 2022 Jul; 102():154112. PubMed ID: 35550220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
    Liu H; Zhang TA; Zhang WY; Huang SR; Hu Y; Sun J
    Exp Neurol; 2023 Nov; 369():114541. PubMed ID: 37714424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
    Wang L; Liu C; Wang L; Tang B
    Eur J Pharmacol; 2023 Apr; 944():175516. PubMed ID: 36758783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of
    Zhang Z; Pang X; Wei Y; Chen H; Jin X; Lv Q
    Brain Inj; 2023 Mar; 37(4):269-281. PubMed ID: 36567616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylnobiletin ameliorates cerebral ischemia-reperfusion injury in rats through Nrf2/HO-1 signaling pathway.
    Huang D; Awad ACA; Tang C; Chen Y
    Environ Toxicol; 2024 Mar; 39(3):1335-1349. PubMed ID: 37955318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice.
    Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y
    Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition.
    Shi M; Wang J; Bi F; Bai Z
    Environ Toxicol; 2022 Jun; 37(6):1529-1542. PubMed ID: 35191607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis.
    Wang Z; Li Y; Ye Y; Zhu H; Zhang J; Wang H; Lei J; Gu L; Zhan L
    Brain Res Bull; 2023 Feb; 193():37-46. PubMed ID: 36435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SET domain containing 7 promotes oxygen-glucose deprivation/reoxygenation-induced PC12 cell inflammation and oxidative stress by regulating Keap1/Nrf2/ARE and NF-κB pathways.
    Pan X; Fan J; Peng F; Xiao L; Yang Z
    Bioengineered; 2022 Mar; 13(3):7253-7261. PubMed ID: 35259059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sestrin1 exerts a cytoprotective role against oxygen-glucose deprivation/reoxygenation-induced neuronal injury by potentiating Nrf2 activation via the modulation of Keap1.
    Yang F; Chen R
    Brain Res; 2021 Jan; 1750():147165. PubMed ID: 33069734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
    Ren X; Yu J; Guo L; Ma H
    Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence marker protein 30 confers neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury.
    Liu W; Zhao H; Su Y; Wang K; Li J; Xue S; Sun X; Qiu Z
    Hum Exp Toxicol; 2021 Mar; 40(3):472-482. PubMed ID: 32909858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
    Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
    Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway.
    Dai Y; Zhang H; Zhang J; Yan M
    Chem Biol Interact; 2018 Mar; 284():32-40. PubMed ID: 29454613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of Swertiamain on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway.
    Wang H; Wei W; Lan X; Liu N; Li Y; Ma H; Sun T; Peng X; Zhuang C; Yu J
    ACS Chem Neurosci; 2019 May; 10(5):2276-2286. PubMed ID: 30753053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid alleviates cerebral ischemic injury in rats by resisting ferroptosis via Nrf2 signaling pathway.
    Li XN; Shang NY; Kang YY; Sheng N; Lan JQ; Tang JS; Wu L; Zhang JL; Peng Y
    Acta Pharmacol Sin; 2024 Feb; 45(2):248-267. PubMed ID: 37833536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeoniflorin alleviates hypoxia/reoxygenation injury in HK-2 cells by inhibiting apoptosis and repressing oxidative damage via Keap1/Nrf2/HO-1 pathway.
    Xing D; Ma Y; Lu M; Liu W; Zhou H
    BMC Nephrol; 2023 Oct; 24(1):314. PubMed ID: 37884904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity.
    Yao H; Xie Q; He Q; Zeng L; Long J; Gong Y; Li X; Li X; Liu W; Xu Z; Wu H; Zheng C; Gao Y
    Oxid Med Cell Longev; 2022; 2022():9626703. PubMed ID: 35669855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
    Xie J; Zhang T; Li P; Wang D; Liu T; Xu S
    Drug Des Devel Ther; 2022; 16():3071-3085. PubMed ID: 36118165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.